Yosef Yarden

17PUBLICATIONS
156CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Diana Drago-Garcia, Suvendu Giri, Rishita Chatterjee

|Jun 28, 2024
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.

Linda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez

|Jan 12, 2024
Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.

Shir Nevo, Noga Frenkel, Noam Kadouri

|Dec 02, 2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.

Lukas Beumers, Efstathios-Iason Vlachavas, Simone Borgoni

|Nov 28, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.

Yael Aylon, Noa Furth, Giuseppe Mallel

Pageof 3

Frequent Collaborators

10 joint publications

Nishanth Belugali Nataraj

9 joint publications

Moshe Oren

5 joint publications

Yael Aylon

5 joint publications

Stefan Wiemann